当前位置： SCI文献检索 > Journal of Global Antimicrobial Resistance期刊下所有文献 > In vitro activity of fosfomycin against mucoid and non-mucoid Pseudomonas aeruginosa strains.

In vitro activity of fosfomycin against mucoid and non-mucoid Pseudomonas aeruginosa strains.

Abstract：

OBJECTIVES:Pseudomonas aeruginosa is the most frequent infectious agent in cystic fibrosis patients. P. aeruginosa resistance to first line antibiotics limits therapeutic options, but the therapeutic potential of older generation antibiotics, such as fosfomycin is under investigation. Fosfomycin does not belong to any other antibiotic class and acts by inhibiting the biosynthesis of the bacterial cell wall during the initial phases. A major problem for the use of fosfomycin against P. aeruginosa is the absence of a clinical breakpoint, the last one of 32 μg/mL was proposed in 2013 by the CA-SFM (Comité de l'Antibiogramme de la Société Française de Microbiologie). METHODS:Sixty-one strains of P. aeruginosa (thirty mucoid and thirty-one non mucoid) were collected from respiratory samples of cystic fibrosis patients. All isolates were identified by MALDI-TOF (Bruker, Bremen, Germany). Fosfomycin MICs against P. aeruginosa were measured using an automated system and confirmed by the gold standard method. RESULTS:There was no significant difference between mucoid and non-mucoid strains. MIC distribution and susceptibility rates were obtained by agar dilution method and from this data we measured MIC50 and MIC90 which were equal to 32 μg/mL and 64 μg/mL, respectively. From automated method results we measured a very major error (VME), major error (ME) and categorical agreement (CA) which were equal to 0%, 11% and 89%, respectively. Comparing automated and agar dilution methods, a Cohen's kappa equal to 73% (0.726) was measured. CONCLUSIONS:Our data suggest that fosfomycin has good effect against mucoid and non-mucoid strains of P. aeruginosa and automated systems can be implemented in clinical microbiology laboratories to assess fosfomycin with rapid and reproducible results.

journal_name

J Glob Antimicrob Resist

journal_title

Journal of global antimicrobial resistance

authors

Bressan A,Rodio DM,Stangherlin F,Puggioni G,Ambrosi C,Arcari G,Carattoli A,Antonelli G,Pietropaolo V,Trancassini M

doi

10.1016/j.jgar.2020.02.014

subject

Has Abstract

pub_date

2020-03-01 00:00:00

pages

328-331

eissn

2213-7165

issn

2213-7173

pii

S2213-7165(20)30043-6

journal_volume

pub_type

杂志文章

在线工具

In vitro activity of fosfomycin against mucoid and non-mucoid Pseudomonas aeruginosa strains.